Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Bezin

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Drug Safety|July 1, 2017
Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting DatabaseCécile Pageot, Julien Bezin, Andy Smith, et al.
Pharmacological Research|July 21, 2020
Risk of bradyarrhythmia related to ticagrelor: A systematic review and meta-analysisIris Pujade, Justine Perino, Clément Mathieu, et al.
Frontiers in Psychiatry|July 18, 2022
Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free UseCélian Bertin, Julien Bezin, Chouki Chenaf, et al.
European Journal of Clinical Pharmacology|September 4, 2017
Impact of pioglitazone regulatory withdrawal on antidiabetic drug use and health in diabetic patientsAntoine Pariente, Yohann Mansiaux, Ana Jarné, et al.
British Journal of Clinical Pharmacology|August 24, 2025
Appropriateness of oxycodone use for acute pain in surgical and obstetric departments using a clinical data warehouseFabien Xuereb, Kilian Trin, Romain Griffier, et al.
European Journal of Epidemiology|September 21, 2022
Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort studyClément Mathieu, Elodie Pambrun, Anne Bénard-Laribière, et al.
Drug Safety|August 2, 2023
Use of Bisphosphonates and the Risk of Skin Ulcer: A National Cohort Study Using Data from the French Health Care Claims DatabaseClément Jambon-Barbara, Claire Bernardeau, Julien Bezin, et al.
Eclinicalmedicine|January 23, 2025
Suicide and suicide attempt in users of GLP-1 receptor agonists: a nationwide case-time-control studyJulien Bezin, Anne Bénard-Laribière, Emilie Hucteau, et al.
Therapie|November 30, 2023
Psychoactive substance intoxication leading to general hospital admission in young and middle-aged people during and after the first lockdownJustine Perino, Hanta Ramaroson, Nathalie Ong, et al.
Pharmacoepidemiology and Drug Safety|August 4, 2017
National trends in use and costs of oral anticancer drugs in France: An 8-year population-based studyPauline Bosco-Lévy, Paul de Boissieu, Amandine Gouverneur, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Drug Safety|July 1, 2017
Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting DatabaseCécile Pageot, Julien Bezin, Andy Smith, et al.
Pharmacological Research|July 21, 2020
Risk of bradyarrhythmia related to ticagrelor: A systematic review and meta-analysisIris Pujade, Justine Perino, Clément Mathieu, et al.
Frontiers in Psychiatry|July 18, 2022
Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free UseCélian Bertin, Julien Bezin, Chouki Chenaf, et al.
European Journal of Clinical Pharmacology|September 4, 2017
Impact of pioglitazone regulatory withdrawal on antidiabetic drug use and health in diabetic patientsAntoine Pariente, Yohann Mansiaux, Ana Jarné, et al.
British Journal of Clinical Pharmacology|August 24, 2025
Appropriateness of oxycodone use for acute pain in surgical and obstetric departments using a clinical data warehouseFabien Xuereb, Kilian Trin, Romain Griffier, et al.
European Journal of Epidemiology|September 21, 2022
Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort studyClément Mathieu, Elodie Pambrun, Anne Bénard-Laribière, et al.
Drug Safety|August 2, 2023
Use of Bisphosphonates and the Risk of Skin Ulcer: A National Cohort Study Using Data from the French Health Care Claims DatabaseClément Jambon-Barbara, Claire Bernardeau, Julien Bezin, et al.
Eclinicalmedicine|January 23, 2025
Suicide and suicide attempt in users of GLP-1 receptor agonists: a nationwide case-time-control studyJulien Bezin, Anne Bénard-Laribière, Emilie Hucteau, et al.
Therapie|November 30, 2023
Psychoactive substance intoxication leading to general hospital admission in young and middle-aged people during and after the first lockdownJustine Perino, Hanta Ramaroson, Nathalie Ong, et al.
Pharmacoepidemiology and Drug Safety|August 4, 2017
National trends in use and costs of oral anticancer drugs in France: An 8-year population-based studyPauline Bosco-Lévy, Paul de Boissieu, Amandine Gouverneur, et al.
Pageof 8